Grail (NASDAQ:GRAL) Shares Gap Down – Here’s What Happened

Grail, Inc. (NASDAQ:GRAL)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $52.60, but opened at $49.04. Grail shares last traded at $49.32, with a volume of 363,066 shares traded.

Analysts Set New Price Targets

A number of analysts have recently weighed in on GRAL shares. Wolfe Research began coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley assumed coverage on shares of Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 price objective for the company.

Grail Stock Performance

The firm has a 50-day simple moving average of $25.78 and a 200 day simple moving average of $18.86.

Institutional Trading of Grail

Several institutional investors and hedge funds have recently bought and sold shares of GRAL. Public Employees Retirement System of Ohio acquired a new position in Grail in the fourth quarter valued at $334,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in Grail in the fourth quarter valued at about $1,201,000. Westwood Holdings Group Inc. purchased a new stake in Grail in the 4th quarter valued at approximately $1,389,000. Squarepoint Ops LLC acquired a new position in Grail during the 4th quarter worth approximately $1,020,000. Finally, Two Sigma Advisers LP purchased a new position in shares of Grail during the 4th quarter worth approximately $345,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.